A breakthrough in the production of malaria vaccines

Australian scientists are approaching the production of malaria vaccine after isolating three proteins that play an important role in human parasites entering red blood cells.

Picture illustrating a laboratory.

Scientists at the Walter and Eliza Hall Institute in Melbourne have studied 33 works on malaria and self-defense antibodies in the blood.

This process allows the separation of 3 proteins MSP3, MSP1 and AMA1, paving the way for the production of anti-malaria vaccines, a parasitic disease, spread to humans through mosquito bites.

The study, published in the journal PLoS Medicine International on January 19, showed that vaccines targeting these proteins could prevent malaria spread, even if the parasite had entered the bloodstream.

According to Dr. James Beeson of the Walter and Eliza Hall Institute, malaria parasites can penetrate red blood cells through dozens of proteins, so anti-malaria vaccines must "fight" with many proteins to paralyze parasites. coincide.

These three proteins are the top candidates for inclusion in anti-malaria vaccines.

Meanwhile, scientists from Q-Pharm and the Queensland Medical Research Institute have published several clinical trials in the process of preparing malaria vaccine.